Contribution: Industrial Research Assistance Program – Contributions to Firms
Evolved Therapeutics Inc.
$490,000.00
Development of a novel bi-paratopic therapeutic antibody discovery platform
FY 2024-25 · 2025-03-01
Summary
The project aims to develop a platform for creating and functionally screening very large multispecific libraries for antibody discovery.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
725243406
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2025-03-01 | 2024-25 | $300,000.00 |
| 1 | 2025-03-01 | 2024-25 | $490,000.00 |
| 2 | 2025-03-01 | 2024-25 | $490,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 59 jours.
Agreement End Date
2026-03-31
Agreement Number
1028865
Agreement Start Date
2025-03-01
Agreement Title
Development of a novel bi-paratopic therapeutic antibody discovery platform
Agreement Title (French)
Développement d’une nouvelle plateforme de découverte d’anticorps thérapeutiques biparatopiques
Agreement Type
Contribution
Agreement Value
$490,000.00
Amendment Date
2025-11-20
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project aims to develop a platform for creating and functionally screening very large multispecific libraries for antibody discovery.
Description (French)
Le projet vise à développer une plateforme pour créer et filtrer fonctionnellement de très grandes bibliothèques multispécifiques pour la découverte d’anticorps.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
725243406
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Evolved Therapeutics Inc.
Recipient Postal Code
V6T 1Z3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2024-2025-Q4-1028865
